Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$13.32 - $19.19 $61,272 - $88,274
-4,600 Reduced 23.83%
14,700 $261,000
Q1 2024

May 15, 2024

SELL
$13.02 - $21.3 $100,254 - $164,010
-7,700 Reduced 28.52%
19,300 $293,000
Q4 2023

Feb 14, 2024

BUY
$6.68 - $18.81 $17,368 - $48,906
2,600 Added 10.66%
27,000 $461,000
Q3 2023

Nov 14, 2023

BUY
$8.36 - $26.5 $84,436 - $267,650
10,100 Added 70.63%
24,400 $203,000
Q2 2023

Aug 14, 2023

SELL
$15.48 - $35.0 $147,060 - $332,500
-9,500 Reduced 39.92%
14,300 $355,000
Q1 2023

May 15, 2023

BUY
$10.23 - $19.34 $103,323 - $195,334
10,100 Added 73.72%
23,800 $357,000
Q4 2022

Feb 14, 2023

SELL
$5.01 - $11.83 $241,983 - $571,389
-48,300 Reduced 77.9%
13,700 $162,000
Q3 2022

Nov 14, 2022

BUY
$4.57 - $8.4 $210,220 - $386,400
46,000 Added 287.5%
62,000 $367,000
Q2 2022

Aug 08, 2022

BUY
$3.74 - $10.66 $59,840 - $170,560
16,000 New
16,000 $68,000
Q1 2022

May 16, 2022

SELL
$7.81 - $20.45 $90,596 - $237,220
-11,600 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$15.2 - $35.51 $39,520 - $92,326
2,600 Added 28.89%
11,600 $220,000
Q3 2021

Nov 15, 2021

BUY
$21.78 - $40.45 $106,722 - $198,205
4,900 Added 119.51%
9,000 $300,000
Q2 2021

Aug 16, 2021

BUY
$32.5 - $48.96 $133,250 - $200,736
4,100 New
4,100 $159,000
Q1 2021

May 17, 2021

SELL
$41.61 - $54.3 $312,075 - $407,250
-7,500 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$25.27 - $54.9 $189,525 - $411,750
7,500 New
7,500 $390,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $3.46B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.